Sihuan Pharma Sees Sales Boost From Expanded Access To Hospitals, Insurance Across Rural China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's pilot programs in health system reforms, aimed at extending access to hospitals and insurance coverage across patches of the countryside, are already boosting sales of cardiovascular drugs and antibiotics for Sihuan Pharmaceutical Holdings Group, according to company executives and analysts
You may also be interested in...
China Set To Launch Sweeping Health System Reforms, Aimed In Part At Reversing Stratified Access To Medicine, Hospitals, Insurance
BEIJING - China's central government is set to launch sweeping reforms of the country's health system, with the ultimate goal of providing universal health care by the year 2020
China’s Race For Pharmaceutical Patents Speeds Up
BEIJING - In just one sign that the race for pharmaceutical patents is speeding up across China, an executive at Sihuan Pharmaceutical Holdings said the company has applied for hundreds of patents over the past two years
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).